Notably, Bourefis et al. found that using a combination of HSP27 and menin serum levels was more accurate for predicting prostate cancer aggressiveness and mortality than PSA [331], suggesting that high serum menin levels may be useful for identifying individuals with prostate cancer who may be at increased risk for aggressive disease and mortality. This evidence concerns the gene PROS1 and prostate carcinoma.